Condition: Multiple SclerosisIntervention: Behavioral: YönetebilirimSponsor: Selcuk UniversityRecruiting Author:
Category: Multiple Sclerosis (MS)
Multiple Sclerosis (MS) related news and clinical trial information
Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients – an Observational Study
Condition: Multiple SclerosisIntervention: Other: OfatumumabSponsor: Novartis PharmaceuticalsRecruiting Author:
PET Imaging of Cyclooxygenase-2 in Multiple Sclerosis
Condition: Multiple SclerosisInterventions: Drug: 11C-MCI; Drug: 11C-PS13Sponsors: National Institute of Mental Health (NIMH); University of MarylandRecruiting Author:
Pathological Basis of MRI Signal Changes in Multiple Sclerosis
Condition: Multiple SclerosisIntervention: Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)Recruiting Author:
A NIS Evaluating Injectable Treatments in Patients With Relapsing Multiple Sclerosis
Condition: Relapsing Multiple SclerosisInterventions: Other: ofatumumab; Other: glatiramer acetate; Other: interferon β1Sponsor: Novartis PharmaceuticalsRecruiting Author:
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Condition: Multiple SclerosisInterventions: Drug: Pioglitazone; Drug: clemastine fumarate; Drug: Dantrolene; Drug: PirfenidoneSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Recruiting Author:
Lower Extremities Closed Kinetic Chain Training for People With MS
Condition: Multiple SclerosisIntervention: Combination Product: Telko plus conventional physical therapy (CPT)Sponsor: Anas Radi Hassan AlashramRecruiting Author:
Tolebrutinib, a Brain-penetrant Bruton s Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
Condition: Multiple SclerosisInterventions: Drug: tolebrutinib 60mg; Drug: tolebrutinib 120mgSponsor: National Institute of Neurological Disorders and Stroke (NINDS)Recruiting Author:
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Condition: Relapsing Multiple SclerosisInterventions: Drug: Remibrutinib; Drug: TeriflunomideSponsor: Novartis PharmaceuticalsRecruiting Author:
Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis
Condition: Progressive Multiple SclerosisInterventions: Drug: Placebo; Drug: Masitinib (4.5)Sponsor: AB ScienceRecruiting Author:
Fatigue and Sleep Quality in Multiple Sclerosis Patients
Condition: Multiple SclerosisIntervention: Other: ReikiSponsor: Istanbul Sabahattin Zaim UniversityRecruiting Author:
Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
Condition: Multiple SclerosisIntervention: Drug: AnakinraSponsor: National Institute of Neurological Disorders and Stroke (NINDS)Recruiting Author: